Success Stories: EB-1A Petition Approved in 12 Days for Postdoctoral Research Fellow in Ohio in the Field of Immunology
Client’s Testimonial:
“Happy to see that my case was approved. Thanks a lot for the support and professionalism you showed during the preparation of my case documents. Special thanks to [North America Immigration Law Group], who helped me a lot and clarified all my questions about filing.”
On February 27th, 2018, we received another EB-1A (Alien of Extraordinary Ability) approval for a Postdoctoral Research Fellow in the Field of Immunology (Approval Notice).
General Field: Immunology
Position at the Time of Case Filing: Postdoctoral Research Fellow
Country of Origin: India
State of Residence at the Time of Filing: Ohio
Approval Notice Date: February 27, 2018
Processing Time: 12 Days (Premium Processing Requested)
Case Summary:
Exactly 12 days after North America Immigration Law Group (WeGreened.com) filed an EB-1A (Alien of Extraordinary Ability) petition on behalf of an Indian postdoctoral research fellow, the USCIS approved it. The reason why our client only waited less than 2 weeks for notification of case approval is because he opted for Premium Processing (PP). PP is a top-up option offered by the USCIS whereby they guarantee cases will be adjudicated within 15 calendar days. Besides paying them an extra $1,225, our client also submitted Form I-907.
Putting together a winning EB1A petition:
Although our client had strong credentials, he needed our help to prove to the USCIS that his work in the field of immunology is important in understanding how immunological disorders develop. First of all, we collated an array of information regarding our client’s high standing as an extraordinary researcher in the field. Supporting evidence such as the 201 times his work was cited, the 10 publications in his name, and the 19 times he conducted peer reviews were listed.
To further strengthen our client’s petition, we detailed his work on autoimmunity and allergy. We also encouraged him to contact a handful of influential immunologists and ask for recommendation letters. Not long after we helped our client narrow down potential recommenders, he returned with six signed letters, one of which contained this statement: “[Client’s] work is therefore critical for the health and safety of those in the U.S. and abroad, and his studies are allowing for better therapeutic options for chronic, life-threatening autoimmune diseases.”
We are extremely pleased that our meticulous efforts paid off and that our client secured EB1A petition approval. Now, all that stands between our client and his green card is the I-485 application. We wish him the best with this and thank him for choosing us to represent his EB1A petition.